These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28123820)

  • 21. Molecular imaging of the 5-HT(1A) receptor in relation to human cognition.
    Borg J
    Behav Brain Res; 2008 Dec; 195(1):103-11. PubMed ID: 18606193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental Serotonergic Agents for the Treatment of Schizophrenia.
    Capuzzi E; Caldiroli A; Ciscato V; Russo S; Buoli M
    J Exp Pharmacol; 2021; 13():49-67. PubMed ID: 33574716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of muscarinic, rather than nicotinic, receptors impairs attention, but does not interact with serotonin depletion.
    Ruotsalainen S; Miettinen R; MacDonald E; Koivisto E; Sirviö J
    Psychopharmacology (Berl); 2000 Feb; 148(2):111-23. PubMed ID: 10663425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 5-HT(1A) receptors in learning and memory.
    Ogren SO; Eriksson TM; Elvander-Tottie E; D'Addario C; Ekström JC; Svenningsson P; Meister B; Kehr J; Stiedl O
    Behav Brain Res; 2008 Dec; 195(1):54-77. PubMed ID: 18394726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catechol-O-methyltransferase, Cognition and Alzheimer's Disease.
    Perkovic MN; Strac DS; Tudor L; Konjevod M; Erjavec GN; Pivac N
    Curr Alzheimer Res; 2018 Mar; 15(5):408-419. PubMed ID: 29231139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors.
    Marsden CA; King MV; Fone KC
    Neuropharmacology; 2011 Sep; 61(3):400-7. PubMed ID: 21414329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice.
    Kim HS; Son YR; Kim SH
    Life Sci; 1999; 64(26):2463-70. PubMed ID: 10403505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Olabarria M; Verkhratsky A; Rodríguez JJ
    Eur J Neurosci; 2010 Jul; 32(1):71-9. PubMed ID: 20576032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function.
    Fone KC
    Neuropharmacology; 2008 Nov; 55(6):1015-22. PubMed ID: 18655798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists.
    Dringenberg HC; Zalan RM
    Brain Res; 1999 Aug; 837(1-2):242-53. PubMed ID: 10434009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of cholinergic functions by serotonin and possible implications in memory: general data and focus on 5-HT(1A) receptors of the medial septum.
    Jeltsch-David H; Koenig J; Cassel JC
    Behav Brain Res; 2008 Dec; 195(1):86-97. PubMed ID: 18400315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic 5-HT7 receptors and cognition.
    Gasbarri A; Pompili A
    Rev Neurosci; 2014; 25(3):311-23. PubMed ID: 24486730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
    García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
    Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease.
    Werner FM; Covenas R
    Curr Pharm Des; 2016; 22(14):2064-71. PubMed ID: 26818863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia.
    Sumiyoshi T; Kunugi H; Nakagome K
    Front Neurosci; 2014; 8():395. PubMed ID: 25538549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of the glutamatergic system on cognition in schizophrenia: A systematic review.
    Thomas EHX; Bozaoglu K; Rossell SL; Gurvich C
    Neurosci Biobehav Rev; 2017 Jun; 77():369-387. PubMed ID: 28414078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour.
    Steckler T; Sahgal A
    Behav Brain Res; 1995 Mar; 67(2):165-99. PubMed ID: 7779290
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.